Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All

UF Health Researchers Develop Unique Model for Studying ALS

April 22, 2016 2:00 pm | by University of Florida | News | Comments

The new mouse model is significant because it closely replicates the symptoms and gene expression patterns found in people who have the most common genetic cause of ALS. 

TOPICS:

Researchers Uncover 'Local Heroes' of Immune System

April 22, 2016 12:44 pm | by Walter + Eliza Hall Institute | News | Comments

Melbourne researchers have uncovered the genes responsible for the way the body fights infection at the point of 'invasion'.

TOPICS:

UN Hears Major Differences on Global Approach to Drug Abuse

April 22, 2016 11:15 am | by Edith M. Lederer, Associated Press | News | Comments

The first U.N. General Assembly special session to address global drug policy in nearly 20 years heard major differences on the approach to drug use on its second day on Wednesday.

TOPICS:
Advertisement

Gateway to The Brain

April 22, 2016 11:09 am | by Duke-NUS Medical School | News | Comments

This is the first molecular model of this critical transporter, and could prove important for the development of therapeutic agents that need to be delivered to the brain.

TOPICS:

University Develops First Diagnostic Blood Test for Parkinson's

April 22, 2016 11:04 am | by Greg Watry, Digital Reporter | Articles | Comments

The university reported the test has undergone trials with 38 people, 29 with Parkinson’s and nine without.

TOPICS:

New Genetic Risk Factors for Myopia Discovered

April 22, 2016 10:59 am | by Johannes Gutenberg Universitaet Manz | News | Comments

Genes and environment determine short-sightedness.

TOPICS:

Novartis Profits Dip as Generic Rival Challenges Cancer Drug

April 22, 2016 10:59 am | by The Associated Press | News | Comments

Shares of Novartis were down 0.7 percent at 74.55 Swiss francs in mid-morning trading on the Six Swiss stock exchange.

TOPICS:

Global Viral Infections Market to Reach $117.6B by 2021

April 22, 2016 10:58 am | by Fiona Chisholm, Analyst, GBI Research | Articles | Comments

The availability of generic drugs is expected to increase due to a series of recent and upcoming patent expirations for key marketed products, particularly within HIV.

TOPICS:
Advertisement

Obesity Is Now Linked to 11 Types of Cancer

April 22, 2016 10:57 am | by Laura Lorenzetti, Fortune | News | Comments

Alcohol and bacon are some of the key culprits.

TOPICS:

Researchers Discover New Pathway That May Trigger Asthma

April 21, 2016 2:56 pm | by University of Pennsylvania | News | Comments

Asthma is a chronic condition that affects more than 25 million people in the United States alone. 

TOPICS:

AbbVie Inks Collaboration with Argenx to Develop Novel Immuno-oncology Target

April 21, 2016 12:44 pm | News | Comments

Under the terms of the agreement, argenx will conduct research and development through IND-enabling studies.

TOPICS:

Novartis’ Muscle Disease Drug Misses Goal in Late-Stage Trial

April 21, 2016 12:13 pm | by Ryan Bushey, Digital Editor | News | Comments

Novartis published their first quarter financial report, which included information on bimagrumab, a drug developed in conjunction with Morphosys to treat a muscle-wasting disease called sporadic inclusion body myositis (sIBM).

TOPICS:

Orphan Status Granted to GW's Cannabis Drug

April 21, 2016 10:23 am | by Ryan Bushey, Digital Editor | Articles | Comments

This disease marks the third treatment indication GW is pursuing.

TOPICS:

Study Finds Explanation for Some Treatment-Resistant Breast Cancers

April 21, 2016 9:45 am | by Vanderbilt University Medical Center | News | Comments

A targeted therapy for triple-negative breast cancer (TNBC), the most aggressive form of breast cancer, has shown potential promise in a recently published study. TNBC is the only type of breast cancer for which there are no currently approved targeted therapies.

TOPICS:

Risperidone: Increased Appetite, Weight Gain in Children Treated for Autism

April 21, 2016 9:32 am | by Emory University | News | Comments

The drug risperidone has been successful in reducing serious behavioral problems in children with autism spectrum disorder (ASD), but researchers have discovered that increased appetite, followed by weight gain, can be a undesirable adverse effect. 

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading